KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Travere Therapeutics (TVTX) Receivables Refunds (2019 - 2021)

Travere Therapeutics' Receivables Refunds history spans 3 years, with the latest figure at $247000.0 for Q4 2021.

  • For Q4 2021, Receivables Refunds fell 98.56% year-over-year to $247000.0; the TTM value through Dec 2021 reached $247000.0, down 98.56%, while the annual FY2021 figure was $247000.0, 98.56% down from the prior year.
  • Receivables Refunds reached $247000.0 in Q4 2021 per TVTX's latest filing, down from $405000.0 in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $20.2 million in Q1 2020 to a low of $247000.0 in Q4 2021.
  • Average Receivables Refunds over 3 years is $10.1 million, with a median of $13.6 million recorded in 2020.
  • Peak YoY movement for Receivables Refunds: surged 1128.82% in 2020, then plummeted 98.56% in 2021.
  • A 3-year view of Receivables Refunds shows it stood at $1.4 million in 2019, then soared by 1128.82% to $17.1 million in 2020, then tumbled by 98.56% to $247000.0 in 2021.
  • Per Business Quant, the three most recent readings for TVTX's Receivables Refunds are $247000.0 (Q4 2021), $405000.0 (Q3 2021), and $400000.0 (Q2 2021).